Patients also attend regular check-ins to monitor their progress
Simultaneously, the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) became operational on January 1, 2026, requiring Medicare Advantage, Medicaid, and CHIP plans to streamline PA with shorter decision timelines (72 hours for expedited, 7 days for standard) and begin publicly reporting PA metrics ( [16] )
Semaglutide, a GLP-1 receptor agonist, has emerged as a potential tool to address weight gain in this population, though it works alongsidenot as a replacement forthyroid medication
Were not just another med spa
Format Match Determines Individual "Best" A high-quality FDA-approved tablet remains "wrong" for someone who cannot afford ongoing treatment without insurance coverage